l -Cys/CSE/H 2 S pathway modulates mouse uterus motility and sildenafil effect-Reference-Cited by-同舟云学术

l -Cys/CSE/H 2 S pathway modulates mouse uterus motility and sildenafil effect

Published:2016-09 Issue: Volume:111 Page:283-289
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Mitidieri Emma,Tramontano Teresa,Donnarumma Erminia,Brancaleone Vincenzo,Cirino Giuseppe,d⿿Emmanuele di Villa Bianca Roberta,Sorrentino Raffaella

Publisher

Elsevier BV

Subject

Pharmacology

Reference33 articles.

1. Uterine contraction and physiological mechanisms of modulation;Wray;Am. J. Physiol.,1993

2. The effect of extracellular adenosine triphosphate on the spontaneous contractility of human myometrial strips;Hutchings;Eur. J. Obstet. Gynecol. Reprod. Biol.,2009

3. In vivo myometrial activity in the rat during the oestrous cycle: studies with a novel technique of video laparoscopy;Crane;Reprod. Fertil. Dev.,1991

4. An l-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy;Yallampalli;Am. J. Obstet. Gynecol.,1994

5. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action;Schmidt;Biochim. Biophys. Acta,1993

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A hydrogen sulphide-releasing non-steroidal anti-inflammatory, ATB-346, significantly attenuates human myometrial contractions;Pharmacological Reports;2024-09-04

2. Hydrogen sulfide dysfunction in metabolic syndrome-associated vascular complications involves cGMP regulation through soluble guanylyl cyclase persulfidation;Biomedicine & Pharmacotherapy;2024-05

3. Therapeutic Potential of Hydrogen Sulfide in Reproductive System Disorders;Biomolecules;2024-04-30

4. Regulatory effects of hydrogen sulfide on the female reproductive system;European Journal of Pharmacology;2024-01

5. The combined uterorelaxant effect of sildenafil and terbutalin in the rat: The potential benefit of co-administration of low doses;Heliyon;2023-12